Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — Q3 FY2023 Earnings Presentation

34 slides from Mitsui Chemicals's earnings presentation, Feb 7, 2024

  1. Slide 1: Financial Summary: Results for 3rd Quarter of FY2023 & Outlook for FY2023

    Financial Summary Results for 3 rd Quarter of FY2023 & Outlook for FY2023 Mitsui Chemicals, Inc. ＜Remarks＞ February 7, 2024 FY2023 indicates the period from April 1, 2023 to March 31, 2024. This summary contains forward-looking statements about the future plans, strategies, belief and performance of

  2. Slide 2: Contents

    Contents 1. Results for 3rd Quarter of FY2023 (April 1, 2023 – December 31, 2023) 1) Trends of Key Market Indicators ･･･ 1 2) Major Investment Projects, etc. ･･･ 2 3) Consolidated Financial Highlights ･･･ 3-4 4) Sales Revenue and Operating Income before Special Items by Business Segment ･･･ 5 (compa

  3. Slide 3: 1. Results for 3rd Quarter of FY2023

    1. Results for 3 rd Quarter of FY2023 (April 1, 2023 – December 31, 2023) Copyright © 2024 Mitsui Chemicals, Inc.

  4. Slide 4: 1) Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2023 FY2023 3Q→ (changes from previous outlook on 3Q 4Q Nov. 8, 2023) 4Q Firm demand Life ＆ Ophthalmic lens materials market (Inventory level adjustments at customers complete) Firm demand to continue ➡ Demand staying firm ➡ Healthcare Solutions Demand staying fi

  5. Slide 5: 2) Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY21 FY22 FY23 FY24~ Orthopedic surgery sector: Japan MDM Business and Capital Alliance January.'22 - Life & Acquisition of agrochemicals business January.'22 - Healthcare Acquisition of ophthalmic lens processing equipment m

  6. Slide 6: 3-1) Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2022 FY2023 Increase Items % 1Q-3Q 1Q-3Q (Decrease) Sales revenue 1,428.9 1,274.5 (154.4) (11%) Operating income before special 110.3 72.4 (37.9) (34%) items (inc. Equity in earnings) 18.4 10.1 (8.3) (45%) Non-recurring it

  7. Slide 7: 3-2) Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials decreased in 1H due to movements to adjust inventory levels in some markets. ［-］ ・Automotive applications increased driven by recovery in automotive production.

  8. Slide 8: 4) Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2022 results) (Billions of Yen) () Denotes a minus Operating income before special Sales revenue Breakdown items Segment FY2022 FY2023 Incr. FY2022 FY2023 Incr. Terms of Volume Cos

  9. Slide 9: 5-1) Life & Healthcare Solutions: Operating Income and Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume in 1H was down due to movements to adjust inventor

  10. Slide 10: 5-2) Mobility Solutions: Operating Income and Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales of solar cell encapsulants remained firm [+]Terms of trade Elastom

  11. Slide 11: 5-3) ICT Solutions: Operating Income and Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Overall sales volume was down due to sluggish demand in semiconductor and sma

  12. Slide 12: 5-4) Basic & Green Materials: Operating Income and Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume was down due to weaker demand [-]Sales volume ・Terms o

  13. Slide 13: 6) Non-recurring Items

    6) Non-recurring Items (Billions of Yen) () Denotes a minus FY2022 FY2023 Incr. Items 1Q-3Q 1Q-3Q (Decr.) Loss (gain) on sales and disposal of non-current assets (1.6) (1.3) 0.3 Impairment loss (4.0) (14.2) (10.2) Others 2.3 3.1 0.8 Non-recurring items total (3.3) (12.4) (9.1) 1. Results for 3 rd Qu

  14. Slide 14: 7) Consolidated Statement of Financial Position

    7) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar. 2023 Dec.2023 (Decr.) Mar. 2023 Dec.2023 (Decr.) Current assets 1,094.3 1,126.8 32.5 Liabilities 1,184.9 1,216.7 31.8 Cash and cash equivalents 186.3 214.6 28

  15. Slide 15: 8) Consolidated Statement of Cash Flow

    8) Consolidated Statement of Cash Flow (Billions of Yen) () Denotes a minus FY2022 FY2023 Incr. Items 1Q-3Q 1Q-3Q (Decr.) Ⅰ．Cash flows from operating activities (a) 44.1 115.0 70.9 Ⅱ．Cash flows from investing activities (b) (67.3) (69.8) (2.5) Free cash flows (a)+(b) (23.2) 45.2 68.4 Ⅲ．Cash flows fr

  16. Slide 16: 2. Outlook for FY2023

    2. Outlook for FY2023 (April 1, 2023 – March 31, 2024) Mitsui Chemicals, Inc. has changed its business segment structure effective April 1, 2022. Results for FY2021 and prior years based on the new business segments are reference figures which have been prepared for the purpose of comparison with fi

  17. Slide 17: 1-1) Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2023 FY2023 Previous FY2022 Incr.(Decr.) Outlook Outlook Items (on Nov 8,2023) 1st Half Full Year 1st Half Full Year Full Year ％ Full Year Sales revenue 951.1 1,879.5 823.7 1,741.0 (138.5) (7%) 1,757.0 Operating

  18. Slide 18: 1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Decrease in vision care materials in 1H due to movements to adjust inventory levels in some markets. ［-］ ・Sales for agrochemicals expected to remain firm. ［+］ Volume ・Autom

  19. Slide 19: 2-1) Life & Healthcare Solutions: Outlook and Business Overview

    2-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): Changes from previous outlook [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger (on Nov. 8, 2023) ・Decrease

  20. Slide 20: 2-2) Mobility Solutions: Outlook and Business Overview

    2-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): Changes from previous outlook [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger (on Nov. 8, 2023) ・Sales volume incre

  21. Slide 21: 2-3) ICT Solutions: Outlook and Business Overview

    2-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): Changes from previous outlook [+] denotes profit trigger Movement of Operating Income before Special Items (on Nov. 8, 2023) [-] denotes loss trigger ・Overall sales volume ex

  22. Slide 22: 2-4) Basic & Green Materials: Outlook and Business Overview

    2-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): Changes from previous outlook [+] denotes profit trigger Movement of Operating Income before Special Items (on Nov. 8, 2023) [-] denotes loss trigger ・Sales volume

  23. Slide 23: 3) Operating Income before Special Items by Business Segment (4Q vs. 3Q)

    3) Operating Income before Special Items by Business Segment (4Q vs. 3Q of FY2023) (Billions of Yen) () Denotes a minus Operating income before special items FY2023 Comments Segment 4Q Incr. [+] denotes profit trigger 3Q [-] denotes loss trigger Outlook (Decr.) Life & Healthcare 7.3 11.5 4.2 [+]Sale

  24. Slide 24: 4) Consolidated Statement of Cash Flow

    4) Consolidated Statement of Cash Flow (Billions of Yen) () Denotes a minus FY2023 FY2023 Incr.(Decr.) Items FY2022 Previous Outlook Outlook (b)-(a) (on Nov 8,2023) Ⅰ．Cash flows from operating activities (a) 101.2 130.0 28.8 130.0 Ⅱ．Cash flows from investing activities (b) (106.3) (106.0) 0.3 (119.0

  25. Slide 25: 3. Appendix

    3. Appendix 1) Performance Trends by Business Segment 2) Trends in Product Prices 3) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 4) Sales Revenue and Operating Income before Special Items by Business Segment 5) Outline of Business Segments 6) Data Highlights Copyright © 2024 M

  26. Slide 26: 1) Performance Trends by Business Segment

    1) Performance Trends by Business Segment 200.0 Basic & Green 40.0 Materials 161.8 180 ICT 47.0 Solutions 113.9 77.8 130 93.0 17.8 85.1 24.0 60.0 Mobility 72.3 23.8 Solutions 19.9 80 9.0 30.2 17.4 49.3 57.0 25.3 33.2 Life & 30 35.6 17.8 65.0 Healthcare Solutions 23.1 24.9 29.2 30.0 14.8 Others (11.0

  27. Slide 27: 2) Trends in Product Prices

    2) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan) : Change in Prices and Raw Materials Prices in Japan / BPA(China), PTA, TDI : Chinese Market Price) (ACP) : Asian contract price Year 2021 2022 2023 Month Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec.

  28. Slide 28: 3-1) Sales Revenue Increase/Decrease by Business Segment

    3-1) Sales Revenue Increase/Decrease (Year on Year) by Business Segment Life & Healthcare （Unit:Billions of yen） () Denotes a minus 売上高 ➢ Volume (4.7) billion yen - Sales of vision care materials and nonwovens decreased. +1.8 ➢ Prices +6.5 billion yen - Foreign exchange impact, etc. Mobility （Unit:B

  29. Slide 29: 3-2) Sales Revenue Increase/Decrease by Business Segment

    3-2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment （Unit:Billions of yen） ICT () Denotes a minus 売上高 ➢ Volume (8.9) billion yen - Sales of semiconductor and smart phone applications decreased. (2.9) ➢ Prices +6.0 billion yen - Foreign exchange impact, etc. （Unit:Billions of yen）

  30. Slide 30: 4) Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Segment FY2022 FY2023 Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Outlook Life & Healthcare Solutions 58.7 63.4 64.7 71.4 57.1 62.0 69.5 86.4 Mobility

  31. Slide 31: 5) Outline of Business Segments

    5) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Medical materials (taurine), Life & Healthcare Nonwovens, Oral Care, Nonwovens (hygiene materials, industrial materials), Solutions Agrochemica

  32. Slide 32: 6-1) Data Highlights

    6-1) Data Highlights () Denotes a minus ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） Total Assets （Billions of Yen） 2,500 Net Sales/Sales Revenue 2,200 2,068.2 2,000 1,935.0 1,879.5 2,000 1,741.0 1,612.7 1,800 1,482.9 *1 1,500 1,328.5 1,339.0 1,211.7 1,558.1 1,212.3 1,600 1,501.1 1,480.1 1,431.3 1,00

  33. Slide 33: 6-2) Data Highlights

    6-2) Data Highlights ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） 250.0 Capital Expenditure （Billions of Yen） Depreciation & Amortization 207.1 180.0 150.0 200.0 168.0 *3 150.0 *2 92.1 96.0 *1 93.2 100.0 76.6 84.2 100.0 81.2 76.3 52.1 45.4 61.9 44.1 45.7 49.5 50.0 50.0 0.0 0.0 '16 '17 '18 '19 '20 '21

  34. Slide 34: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2024 Mitsui Chemicals, Inc.

Mitsui Chemicals — Q3 FY2023 Earnings Presentation on 6ix